Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2025-12-24 @ 12:43 PM
NCT ID:
NCT06574061
Brief Summary:
The objective of the study was to evaluate in routine practice the benefits of sublingual allergen immunotherapy (SLIT) for allergic patients with allergic rhinitis (AR), with or without asthma, according to various methods of use (treatment regimen: formulation type, dose, duration, initiation) and type of allergen (grass pollen, tree pollen, herbaceous pollen, house dust mites, animal dander, moulds and poly-reactive types).
Detailed Description:
The treatment considered was any SLIT (tablet or liquid forms) accepted by the patient and the parent(s) in the case of minor patients. The treatment was taken as prescribed by the observing physician.
The expected benefits for patients after approximately 6 and 12 months after initiation of SLIT included:
* Decreased intensity of symptoms
* Decreased discomfort
* Decreased consumption of symptomatic treatments or associated treatments (especially in asthmatic patients)
* Improved quality of life
* Reduced absenteeism from school or work
* Beneficial impact on leisure activities.
Study:
NCT06574061
Study Brief:
Protocol Section:
NCT06574061